Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Public ClinicalTrials.gov record NCT00322257. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted in the United States of America (USA) and Canada. The aim of this research is to compare the efficacy (reduction in HbA1c and blood glucose) and pulmonary safety (pulmonary function, chest x-rays) of mealtime inhaled insulin with subcutaneous insulin aspart both in combination with insulin determir in Type 1 Diabetes.
Study identification
- NCT ID
- NCT00322257
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 596 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2006
- Primary completion
- Apr 1, 2008
- Completion
- Apr 1, 2008
- Last update posted
- Sep 4, 2018
2006 – 2008
United States locations
- U.S. sites
- 86
- U.S. states
- 34
- U.S. cities
- 81
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Birmingham | Alabama | 35294 | — |
| Novo Nordisk Investigational Site | Tuscaloosa | Alabama | 35406 | — |
| Novo Nordisk Investigational Site | Concord | California | 94520 | — |
| Novo Nordisk Investigational Site | Encino | California | 91436 | — |
| Novo Nordisk Investigational Site | Escondido | California | 92025 | — |
| Novo Nordisk Investigational Site | Fresno | California | 93720 | — |
| Novo Nordisk Investigational Site | Inglewood | California | 90301 | — |
| Novo Nordisk Investigational Site | La Jolla | California | 92037 | — |
| Novo Nordisk Investigational Site | Mission Viejo | California | 92691 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | San Mateo | California | 94401 | — |
| Novo Nordisk Investigational Site | Santa Barbara | California | 93105 | — |
| Novo Nordisk Investigational Site | Tustin | California | 92780 | — |
| Novo Nordisk Investigational Site | Vista | California | 92084 | — |
| Novo Nordisk Investigational Site | Walnut Creek | California | 94598 | — |
| Novo Nordisk Investigational Site | Aurora | Colorado | 80045 | — |
| Novo Nordisk Investigational Site | Colorado Springs | Colorado | 80909 | — |
| Novo Nordisk Investigational Site | New Britain | Connecticut | 06050 | — |
| Novo Nordisk Investigational Site | Norwalk | Connecticut | 06851 | — |
| Novo Nordisk Investigational Site | Waterbury | Connecticut | 06708 | — |
| Novo Nordisk Investigational Site | Boca Raton | Florida | 33433 | — |
| Novo Nordisk Investigational Site | Hollywood | Florida | 33021 | — |
| Novo Nordisk Investigational Site | Lake Mary | Florida | 32746 | — |
| Novo Nordisk Investigational Site | Melbourne | Florida | 32901 | — |
| Novo Nordisk Investigational Site | Merritt Island | Florida | 32953 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33136 | — |
| Novo Nordisk Investigational Site | West Palm Beach | Florida | 33401 | — |
| Novo Nordisk Investigational Site | Athens | Georgia | 30606 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30318 | — |
| Novo Nordisk Investigational Site | Savannah | Georgia | 31406 | — |
| Novo Nordisk Investigational Site | Honolulu | Hawaii | 96813 | — |
| Novo Nordisk Investigational Site | Honolulu | Hawaii | 96814 | — |
| Novo Nordisk Investigational Site | Idaho Falls | Idaho | 83404-7596 | — |
| Novo Nordisk Investigational Site | Chicago | Illinois | 60607 | — |
| Novo Nordisk Investigational Site | Peoria | Illinois | 61615 | — |
| Novo Nordisk Investigational Site | Springfield | Illinois | 62711 | — |
| Novo Nordisk Investigational Site | Lafayette | Indiana | 47904 | — |
| Novo Nordisk Investigational Site | New Albany | Indiana | 47150 | — |
| Novo Nordisk Investigational Site | Des Moines | Iowa | 50314 | — |
| Novo Nordisk Investigational Site | Shawnee Mission | Kansas | 66204 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Baton Rouge | Louisiana | 70808 | — |
| Novo Nordisk Investigational Site | Scarborough | Maine | 04074 | — |
| Novo Nordisk Investigational Site | Hyattsville | Maryland | 20782 | — |
| Novo Nordisk Investigational Site | Springfield | Massachusetts | 01199 | — |
| Novo Nordisk Investigational Site | Waltham | Massachusetts | 02453 | — |
| Novo Nordisk Investigational Site | Bloomington | Minnesota | 55420 | — |
| Novo Nordisk Investigational Site | Duluth | Minnesota | 55805 | — |
| Novo Nordisk Investigational Site | Minneapolis | Minnesota | 55416-2699 | — |
| Novo Nordisk Investigational Site | Tupelo | Mississippi | 38801 | — |
| Novo Nordisk Investigational Site | Jefferson City | Missouri | 65109 | — |
| Novo Nordisk Investigational Site | Kansas City | Missouri | 64114 | — |
| Novo Nordisk Investigational Site | St Louis | Missouri | 63141 | — |
| Novo Nordisk Investigational Site | Butte | Montana | 59701 | — |
| Novo Nordisk Investigational Site | Omaha | Nebraska | 68114 | — |
| Novo Nordisk Investigational Site | Dover | New Hampshire | 03820 | — |
| Novo Nordisk Investigational Site | Hampton | New Hampshire | 03842 | — |
| Novo Nordisk Investigational Site | Lawrenceville | New Jersey | 08648 | — |
| Novo Nordisk Investigational Site | Albany | New York | 12206 | — |
| Novo Nordisk Investigational Site | New Hyde Park | New York | 11042 | — |
| Novo Nordisk Investigational Site | Rochester | New York | 14642 | — |
| Novo Nordisk Investigational Site | Asheville | North Carolina | 28803 | — |
| Novo Nordisk Investigational Site | Greenville | North Carolina | 27834 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45267 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44122 | — |
| Novo Nordisk Investigational Site | Dayton | Ohio | 45406 | — |
| Novo Nordisk Investigational Site | Kettering | Ohio | 45429 | — |
| Novo Nordisk Investigational Site | Mentor | Ohio | 44060 | — |
| Novo Nordisk Investigational Site | Medford | Oregon | 97504 | — |
| Novo Nordisk Investigational Site | Hershey | Pennsylvania | 17033 | — |
| Novo Nordisk Investigational Site | Norristown | Pennsylvania | 19401 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19107 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37404 | — |
| Novo Nordisk Investigational Site | Chattanooga | Tennessee | 37411 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75231 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75246 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75390-8858 | — |
| Novo Nordisk Investigational Site | Midland | Texas | 79707 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78229 | — |
| Novo Nordisk Investigational Site | Ogden | Utah | 84403 | — |
| Novo Nordisk Investigational Site | Olympia | Washington | 98502 | — |
| Novo Nordisk Investigational Site | Renton | Washington | 98057 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99208 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
Recently updated Diabetes trials
Other public records listing Diabetes. Sorted by last update posted; newest first. Not a recommendation.
- NCT07784127: Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation Not yet recruiting
- NCT02262806: Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy Active, not recruiting
- NCT07748858: Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities Recruiting
- NCT05561595: Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma Recruiting
- NCT05912647: Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes Recruiting
- NCT07676188: Leveraging Interventions for Needs and Knowledge in Diabetes (LINKD) Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00322257, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2018 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00322257 live on ClinicalTrials.gov.